Indication
Mucosal Immunity
1 clinical trial
1 product
1 drug
Clinical trial
Lung Immune Challenge Study Controlled Exposure to Inhaled Resiquimod (R848) to Study Mechanisms of InflammationStatus: Recruiting, Estimated PCD: 2025-05-01
Product
R848Drug
Varlilumab